Calvopiña, K., Umland, K., Rydzik, A., Hinchliffe, P., Brem, J., Spencer, J., . . . Avison, M. (2016). Sideromimic Modification of Lactivicin Dramatically Increases Potency against Extensively Drug-Resistant Stenotrophomonas maltophilia Clinical Isolates. American Society for Microbiology.
Citação norma ChicagoCalvopiña, K., K. Umland, A. Rydzik, P. Hinchliffe, J. Brem, J. Spencer, C. Schofield, and M. Avison. Sideromimic Modification of Lactivicin Dramatically Increases Potency Against Extensively Drug-Resistant Stenotrophomonas Maltophilia Clinical Isolates. American Society for Microbiology, 2016.
Citação norma MLACalvopiña, K., et al. Sideromimic Modification of Lactivicin Dramatically Increases Potency Against Extensively Drug-Resistant Stenotrophomonas Maltophilia Clinical Isolates. American Society for Microbiology, 2016.